IL3RA and leukemia: In particular, allogeneic CAR.CD123-NK cells mediate significant cytotoxicity against the CD123+ cell line and primary AML blasts, providing encouraging data that the innate activity of NK cells could be optimized by the addition of CAR to overcome the leukaemia resistance already largely described in patients receiving NK cells through adoptive transfer [52].